Ceritinib/crizotinibDevelopment of resistance in EML4-ALK-positive non-small cell lung cancer: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2017年 / 1635卷 / 1期
关键词：
D O I：
10.1007/s40278-017-25324-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：75 / 75
相关论文
共 50 条
  • [41] Targeting EML4-ALK driven non-small cell lung cancer (NSCLC)
    Moran, Teresa
    Quiroga, Vanesa
    Llanos Gil, Maria de Los
    Vila, Laia
    Pardo, Nuria
    Carcereny, Enric
    Capdevila, Laia
    Munoz-Marmol, Ana M.
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (02) : 128 - 141
  • [42] EML4-ALK fusion transcripts in immunohistochemically ALK-positive non-small cell lung carcinomas
    Shinmura, Kazuya
    Kageyama, Shinji
    Igarashi, Hisaki
    Kamo, Takaharu
    Mochizuki, Takahiro
    Suzuki, Kazuya
    Tanahashi, Masayuki
    Niwa, Hiroshi
    Ogawa, Hiroshi
    Sugimura, Haruhiko
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2010, 1 (02) : 271 - 275
  • [43] EML4-ALK-Positive Pulmonary Adenocarcinoma with an Unusual Metastatic Pattern: A Case Report
    Diem, Stefan
    Fruh, Martin
    Rodriguez, Regulo
    Liechti, Peter
    Rothermundt, Christian
    CASE REPORTS IN ONCOLOGY, 2013, 6 (02): : 316 - 319
  • [44] Cerivastatin overcomes the acquired resistance to crizotinib in EML4-ALK positive non-small cell lung cancer by controlling YAP activation
    Yun, Miran
    Choi, Hun Mi
    Pyo, Kyoung Ho
    Cho, Byoung Chul
    CANCER RESEARCH, 2017, 77
  • [45] EMT is associated with, but does not drive resistance to ALK inhibitors among EML4-ALK non-small cell lung cancer
    Gower, Arjan
    Hsu, Wei-Hsun
    Hsu, Shuo-Tse
    Wang, Yisong
    Giaccone, Giuseppe
    MOLECULAR ONCOLOGY, 2016, 10 (04) : 601 - 609
  • [46] EGFR and EML4-ALK Updated Therapies in Non-Small Cell Lung Cancer
    de Mello, Ramon Andrade
    Liu, Davi J. J.
    Aguiar, Pedro N., Jr.
    Tadokoro, Hakaru
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2016, 11 (04) : 393 - 400
  • [47] Primary resistance to alectinib in a patient with STRN-ALK-positive non-small cell lung cancer: A case report
    Sun, Kunyan
    Nie, Ligong
    Nong, Lin
    Cheng, Yuan
    THORACIC CANCER, 2021, 12 (12) : 1927 - 1930
  • [48] Overcoming the resistance to Crizotinib in patients with Non-Small Cell Lung Cancer harboring EML4/ALK translocation
    Perez, Cesar A.
    Velez, Michel
    Raez, Luis E.
    Santos, Edgardo S.
    LUNG CANCER, 2014, 84 (02) : 110 - 115
  • [49] EML4-ALK biology and drug resistance in non-small cell lung cancer: a new phase of discoveries
    Elshatlawy, Mariam
    Sampson, Josephina
    Clarke, Katy
    Bayliss, Richard
    MOLECULAR ONCOLOGY, 2023, 17 (06) : 950 - 963
  • [50] CrizotinibDevelopment of resistance in non-small cell lung cancer, and various toxicities: 2 case reports
    Reactions Weekly, 2021, 1880 (1) : 139 - 139
12345